Publications by authors named "Negar Molazadeh"

Claim this Profile
S
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice.
Hesham Abboud, Brian Steingo, Diana Vargas, Julie Patel, Mary Alissa Willis, Negar Molazadeh

Mult Scler J Exp Transl Clin· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series.
Hesham Abboud, Brian Steingo, Diana Vargas, Julie Patel, Nancy Nealon, Negar Molazadeh

J Neuroimmunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis.
Evan Madill, Brian C Healy, Negar Molazadeh, Mariann Polgar-Turcsanyi, Bonnie I Glanz

Ann Clin Transl Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated disease.
Philippe Antoine Bilodeau, Anastasia Vishnevetsky, Negar Molazadeh, Itay Lotan, Monique Anderson

Mult Scler· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Negar Molazadeh, Philippe A Bilodeau, Rebecca Salky, Gauruv Bose, Itay Lotan

J Neurol Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis.
Negar Molazadeh, Tetsuya Akaishi, Gauruv Bose, Shuhei Nishiyama, Tanuja Chitnis

Mult Scler Relat Disord· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease.
Itay Lotan, John J Chen, Yael Hacohen, Omar Abdel-Mannan, Sara Mariotto, Negar Molazadeh

Mult Scler· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD).
Itay Lotan, Gabriela Romanow, Rebecca Salky, Negar Molazadeh, Anastasia Vishnevetsky

Ann Clin Transl Neurol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple types of relapses in MOG antibody disease.
Michael Levy, Negar Molazadeh, Philippe Antoine Bilodeau, Anastasia Vishnevetsky, Itay Lotan

Mult Scler Relat Disord· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population.
Negar Molazadeh, Mohammad Ali Sahraian, Mahsa Ghajarzadeh

Caspian J Intern Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review.
Negar Molazadeh, Gauruv Bose, Itay Lotan, Michael Levy

Mult Scler J Exp Transl Clin· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Catching COVID-19 Infection during Pandemic Stage in Patients with Multiple Sclerosis (MS).
Mahsa Ghajarzadeh, Omid Mirmosayyeb, Negar Molazadeh, Mohammad Ali Sahraian, Simona Bonavita

Int J Prev Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorder.
Negar Molazadeh, Angeliki G Filippatou, Eleni S Vasileiou, Michael Levy, Elias S Sotirchos

J Neuroimmunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and incidence of multiple sclerosis in Ardabil, Northwest of Iran.
Negar Molazadeh, Farnam Mohebi, Davar Altafi, Mohammad Ali Sahraian

Mult Scler Relat Disord· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric multiple sclerosis and its familial recurrence: A population based study (1999-2017).
Sharareh Eskandarieh, Mohammad Ali Sahraiain, Negar Molazadeh, Abdorreza Naser Moghadasi

Mult Scler Relat Disord· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder.
Sharareh Eskandarieh, Abdorreza Naser Moghadasi, Mohammad Ali Sahraiain, Amir Reza Azimi, Negar Molazadeh

Iran J Neurol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran.
Sharareh Eskandarieh, Negar Molazadeh, Abdorreza Naser Moghadasi, Amir Reza Azimi, Mohammad Ali Sahraian

Mult Scler Relat Disord· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis